Health
Patients with invasive lobular carcinoma could benefit from additional adjuvant therapy – News-Medical.Net
New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possib…
Reviewed by Emily Henderson, B.Sc.Oct 1 2020
New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
Adjuvant treatments, such as chemotherapy, radiation therapy or targeted therapies, are not usually offered to ILC patients after surgery as the disease is slo…
-
Noosa News20 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News18 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News18 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News19 hours agoGood character references restricted in rape cases in Queensland